Pune, India -- (SBWIRE) -- 04/13/2019 -- The report on Cell-based Assays Market by products and services(consumables, software, services), applications(drug discovery, basic research, predictive toxicology and others), end user(contract research organizations, academic & government institutions and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Cell-based Assays Market is projected to grow at a CAGR in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by a significant contribution by North America (Leading region) region to this market. The global cell-based assays market is expected to grow at a CAGR between 8.0% and 8.5 % over the forecast period of 2017 - 2023.

Ask for Sample Copy of Research Report with Table of Content @
https://www.infiniumglobalresearch.com/reports/sample-request/711

Cell-based Assays Market: Industry Insights

Cell-based assays refer to as different experiments based on the use of live cells. There are a variety of assays that measure toxicity, cell proliferation, motility, production of a measurable product, and morphology. Additionally, cell-based assays are commonly used for cytotoxicity testing, to determine the biological activity of drug product and drug substance, and to determine the mechanism of action (MOA). However, cell-based assays can be grouped into cell death assays, cell proliferation assays, cell signaling assays, and reporter gene assays.

Cell-based Assays Market: Drivers and Restraints

The growing use of cell-based assays in drug discovery, especially since drug development is augmenting the growth of cell-based assays market. Moreover, cell-based assays provide a cost-effective and reliable indication of drug activity in a living system. The incidence of cardiovascular diseases and diabetes and increasing availability of funds & investment for research have a positive impact on the growth of the market. The increasing role of cell-based assays in pharmaceutical and biotech companies are also fueling the demand for cell-based assays. However, the high cost of assay instruments may restrain the growth of the market. Furthermore, the adoption of high-throughput screening for drug discovery augments the demand for cell-based assay market. Development of new technologies such as 3D cell-based assays offers profitable opportunities for Cell-based assays Market growth in the coming years.

Ask Discount for the latest research report @
https://www.infiniumglobalresearch.com/reports/request-discount/711

Cell-based Assays Market: Segmentation

The global cell-based assays market is segmented into products and services, applications, and end user. The products and services of cell-based assays include instruments, consumables, software, and services. Consumables segments are projected holds maximum share in this market. Growing adoption of cell-based consumables by prominent biopharmaceutical companies reflecting positively on this segment. The applications segment includes drug discovery, basic research, predictive toxicology, ADME studies, and other applications. On the basis of end-user pharmaceutical & biotechnology companies, contract research organizations, academic & government institutions, and other end users.

Cell-based Assays Market: Regional Analysis

Among the geographies, North America generated the highest revenue in the cell-based assays market followed by Europe. The growth of cell-based assays market is attributed due to growing drug-related research and development activities, and the existence of a large number of pharmaceutical and biotechnology companies in this North America region. The Asia-Pacific region is anticipated to grow at a higher rate during the forecast period owing to expanding research funding by the government.

Browse Detailed TOC, Description, and Companies Mentioned in Report @
https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-cell-based-assays-market

Cell-based Assays Market: Competitive Landscape

The prominent players in the global cell-based assays market include Perkinelmer, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, General Electric Company, Merck KGaA, Danaher Corporation, Charles River Laboratories, Inc., Cisbio Bioassays, Promega Corporation, and Cell Biolabs Inc.

NanoSurface Biomedical Launches New Drug Screening Platform with Structurally Matured Human Heart Tissues Derived from Stem Cells

In March 2019, NanoSurface Biomedical, a leading provider of biomimetic cell-based assay products and services, announced the launch of the NanoSurface Car(ina)™ platform for highly predictive pre-clinical drug screening, using structurally matured human induced pluripotent stem cell (iPSC) derived heart tissues. This innovative human stem cell-based technology enables drug developers to accurately test the safety and efficacy of new drugs earlier in the drug development process and promises to help get safer medicines to market in less time and at a lower cost.

Reasons to Buy this Report:

- Comprehensive analysis of global as well as regional markets of the Cell-based Assays.

- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2023.

- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.

- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.